Emyria losses deepen as drug development takes centre stage by Steve Jones March 1, 2022April 29, 2024 Emyria saw sales revenue decline by a third in the first six months of the financial […]
TGA releases findings on MDMA and psilocybin as mental health treatments by Martin Lane October 5, 2021April 26, 2024
Company news: Emyria; Medibis; Incannex; Eqalis; Greenfern; Creso Pharma; Highlands Investments by Martin Lane August 12, 2021April 26, 2024
